Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals

BSE482.45-5.25 (-1.08 %)

PREV CLOSE ( ) 487.70

OPEN PRICE ( ) 488.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 30673

TODAY'S LOW / HIGH ( )477.70 494.00

52 WK LOW / HIGH ( )307.9 571.95

NSE482.15-5.45 (-1.12 %)

PREV CLOSE( ) 487.60

OPEN PRICE ( ) 489.80

BID PRICE (QTY) 482.15 (187)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 152330

TODAY'S LOW / HIGH( ) 477.00 494.80

52 WK LOW / HIGH ( )307.25 572

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-03 1988

Management Info

- Chairman Shivakumar Pattabhiraman - Managing Director

Registered Office

Address Sarita Vihar,Delhi - Mathura Road,,
New Delhi,
Delhi-110076

Phone 011- 26925858 / 26925801

Email imcl@apollohospitals.com

Website www.apollohospdelhi.com

Registrars Details

MUFG Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

01Sep Indraprastha Medical Corporation infor
Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (L..

17Jun Indraprastha Medical Corporation infor
Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Di..

05May Indraprastha Medical Corporation infor
Indraprastha Medical Corporation has informed that meting of the Board o..

04Feb Indraprastha Medical Corporation infor
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..

14Jan Indraprastha Medical Corp informs abou
Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (L..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	514.6	1609.9
Gross Profit	683.1	2163.2
Operating Profit	800.5	2669.2
Net Sales	3650.6	13563.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Shalby (BSE) 219.15 (11.78%)	M.Cap ( in Cr)2367.03
Vijaya Diagnostic (BSE) 1107.05 (1.71%)	M.Cap ( in Cr)11372.16
Yatharth Hospital (BSE) 781.70 (1.61%)	M.Cap ( in Cr)7532.02
Krsnaa Diagnostics (BSE) 840.75 (1.23%)	M.Cap ( in Cr)2727.28
Max Healthcare Inst (BSE) 1170.20 (0.76%)	M.Cap ( in Cr)113771.11

Shareholding Pattern

	PROMOTERS	51%
	NON-INSTITUTION	42.72%
	MUTUAL FUNDS/UTI	2.62%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Small Cap Fund(G)	0.39
Motilal Oswal BSE H...	0.16
Bandhan BSE Healthc...	0.16

Risk Disclosures on Derivatives

Smart Quotes

INDRAPRASTHA MEDICAL CORPORATION LTD.